| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |